Concepedia

Jae B. Kim

JB

Statistics

Publications

4

Citations

1.1K

H-Index

4

Active since

2012

Affiliations

Amgen (United States)(Current)

Jacksonville Center for Clinical Research

Jae B. Kim is an author at Amgen (United States) specializing in medicine, pharmacotherapy, and atherosclerosis.

Top concepts

MedicinePharmacologyAtherosclerosisPharmacotherapyCardiovascular DiseaseHealthCardiologyPhysiologyHeart FailureCardiac Physiology

Publications per year

2012–2016

4

Publications

4

Anti-PCSK9 Monotherapy for Hypercholesterolemia

Michael J. Koren, Pernille Lundqvist, Michael A. Bolognese et al. · Journal of the American College of Cardiology · 2014 · 399 citations

Lipid Disorder, Anti-pcsk9 Monotherapy, Cardiovascular Disease +6

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study

Michael J. Koren, Robert C. Scott, Jae B. Kim et al. · The Lancet · 2012 · 359 citations

Lipid Disorder, Cardiovascular Disease, Hyperlipidemia +4

Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure

John R. Teerlink, G. Michael Felker, John J.V. McMurray et al. · Journal of the American College of Cardiology · 2016 · 221 citations · Full text

A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy

Joshua A. Stern, Svetlana Markova, Yu Ueda et al. · PLoS ONE · 2016 · 125 citations · Full text

Molecular Pharmacology, Cardiac Muscle, Heart Failure +13

1–4 of 4